Abstract:As the global burden of atherosclerotic cardiovascular disease continues to rise, there is an increased demand for improved imaging techniques for earlier detection of atherosclerotic plaques and new therapeutic targets. Plaque lesions, vulnerable to rupture and thrombosis, are thought to be responsible for the majority of cardiovascular events, and are characterized by a large lipid core, a thin fibrous cap, and neovascularization. In addition to supplying the plaque core with increased inflammatory factors, these pathological neovessels are tortuous and leaky, further increasing the risk of intraplaque hemorrhage. Clinically, plaque neovascularization has been shown to be a significant and independent predictor of adverse cardiovascular outcomes. Microvessels can be detected through contrast-enhanced ultrasound (CEUS) imaging, however, clinical assessment in vivo is generally limited to qualitative measures of plaque neovascularization. There is no validated standard for quantitative assessment of the microvessel networks found in plaques. Advances in our understanding of the pathological mechanisms underlying plaque neovascularization and its significant role in the morbidity and mortality associated with atherosclerosis have made it an attractive area of research in translational medicine. Current areas of research include the development of novel therapeutic and diagnostic agents to target plaque neovascularization stabilization. With recent progress in nanotechnology, nanoparticles have been investigated for their ability to specifically target neovascularization. Contrast microbubbles have been similarly engineered to carry loads of therapeutic agents and can be visualized using CEUS. This review summarizes the pathogenesis, diagnosis, clinical significance of neovascularization, and importantly the emerging areas of theranostic tool development.

Current advances in the imaging of atherosclerotic vulnerable plaque using nanoparticles

Aiming at Early-Stage Vulnerable Plaques: A Nanoplatform with Dual-Mode Imaging and Lipid-Inflammation Integrated Regulation for Atherosclerotic Theranostics

Advances of nanoparticle-mediated diagnostic and theranostic strategies for atherosclerosis

Recent Advances in Molecular Imaging of Atherosclerotic Plaques and Thrombosis

Emerging Nanoprobes for the Features Visualization of Vulnerable Atherosclerotic Plaques

Intravascular Imaging of Atherosclerosis by Using Engineered Nanoparticles

Current Advances in the Diagnostic Imaging of Atherosclerosis: Insights into the Pathophysiology of Vulnerable Plaque

Engineering Nanoplatforms for Theranostics of Atherosclerotic Plaques

Novel imaging modalities for the identification of vulnerable plaques

Novel ultrasound techniques in the identification of vulnerable plaques-an updated review of the literature

Nanoparticles as Drug Delivery Systems for the Targeted Treatment of Atherosclerosis

Advances in nano-delivery systems based on diagnosis and theranostics strategy for atherosclerosis

Research progress of nuclear medicine imaging in detection of vulnerable atherosclerotic plaques

Current targeting strategies and advanced nanoplatforms for atherosclerosis therapy

Novel theranostic approaches to neovascularized atherosclerotic plaques

A novel method for the diagnosis of atherosclerosis based on nanotechnology

Nanomedicine for Diagnosis and Treatment of Atherosclerosis

Exploring atherosclerosis imaging with contrast-enhanced MRI using PEGylated ultrasmall iron oxide nanoparticles

Detecting Vulnerable Carotid Plaque and Its Component Characteristics: Progress in Related Imaging Techniques

Molecularly targeted nanomedicine enabled by inorganic nanoparticles for atherosclerosis diagnosis and treatment

Scavenger Receptor-Ai-targeted Ultrasmall Gold Nanoclusters Facilitate in Vivo MR and Ex Vivo Fluorescence Dual-Modality Visualization of Vulnerable Atherosclerotic Plaques.